- Home
- MLAB vs ITIC Comparison
MLAB vs ITIC Comparison
Compare MLAB & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MLAB | ITIC |
|---|---|---|
| Founded | 1982 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Specialty Insurers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.8M | 431.1M |
| IPO Year | 1995 | 1995 |
Fundamental Metrics
Financial Performance| Metric | MLAB | ITIC |
|---|---|---|
| Price | $82.61 | $216.34 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $94.00 | N/A |
| AVG Volume (30 Days) | ★ 116.1K | 11.4K |
| Earning Date | 02-03-2026 | 05-07-2026 |
| Dividend Yield | 0.80% | ★ 4.80% |
| EPS Growth | ★ 99.24 | 13.02 |
| EPS | 1.95 | ★ 18.57 |
| Revenue | N/A | ★ $272,755,000.00 |
| Revenue This Year | $6.07 | N/A |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | $41.18 | ★ $11.96 |
| Revenue Growth | N/A | ★ 5.60 |
| 52 Week Low | $59.63 | $190.20 |
| 52 Week High | $130.12 | $288.98 |
Technical Indicators
Market Signals| Indicator | MLAB | ITIC |
|---|---|---|
| Relative Strength Index (RSI) | 45.24 | 31.22 |
| Support Level | $69.73 | $209.71 |
| Resistance Level | $89.69 | $221.39 |
| Average True Range (ATR) | 4.40 | 5.91 |
| MACD | -0.87 | 0.24 |
| Stochastic Oscillator | 46.07 | 3.14 |
Price Performance
Historical ComparisonAbout MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.